ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
18.16
-0.24 (-1.30%)
At close: Jun 27, 2025, 4:00 PM
18.06
-0.10 (-0.55%)
After-hours: Jun 27, 2025, 7:56 PM EDT
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $4.34 billion as of June 27, 2025. Its market cap has increased by 78.46% in one year.
Market Cap
4.34B
Enterprise Value
4.31B
1-Year Change
78.46%
Ranking
Category
Stock Price
$18.16
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $4.34B, an increase of 8,536.28%. That is a compound annual growth rate of 46.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 4.39B | 8.35% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |